EU: CE marked for treatment of Major Depressive Disorder
MagVenture TMS Therapy® is CE marked for “Treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from two prior antidepressant medications, at or above the minimal effective dose and duration in the current episode”.
Clinical benefit: For subjects responding to the treatment of Major Depressive Disorder, who have symptoms of comorbid anxiety, the clinical benefit can additionally include an improvement of anxiety symptoms.
EU: CE marked for Addiction
MagVenture TMS Therapy® is CE marked for “Treatment of psychoactive substance use disorder (PSUD) in adult patients”.
EU: CE marked for adjunct treatment of OCD
MagVenture TMS Therapy® is CE marked “as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
EU: CE marked for diagnostic use
The MagPro® is intended as an electro-physiological aid to assess diagnosis and to monitor diseases of the central and peripheral nervous system, based on the use of Motor Evoked Potential (MEP).